JPRN-UMIN000001560已完成2 期
A randomized phase II trial of adjuvant chemotherapy with UFT/LV versus S-1 following curative resection for stage III colorectal cancer - A randomized phase II trial of UFT/LV versus S-1 adjuvant therapy in patients with stage III colorectal cancer
Boso Clinical Oncology Group0 个研究点目标入组 140 人开始时间: 2008年12月10日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 140
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Severe postoperative complication 2. Serious coexisting illness 1)uncontrolled diabetes mellitus and hypertension 2)history of myocardial infarction, unstable angina within 6 months prior to the registrationsevere 3)pulmonary dysfunction 3. Active diarrhea 4. Multiple cancer 5. Pregnant 6. Disqualified by attending doctor
研究者
相似试验
招募中
2 期
A phase II randomized trial of adjuvant chemotherapy for the patients completely resected pathological stage IB(T>5cm), II, IIIA Non Small Cell Lung Cancer comparing S-1 / S-1 with CDDPnon-small cell lung cancerJPRN-UMIN000001765Kyushu University,Graduate School of Medical Science,Department of Surgery and Science140
已完成
2 期
A randomized phase II trial of adjuvant Chemotherapy with Gemcitabine alone, S-1 alone, versus gemcitabine and S-1 in patients with resected pancreatic cancerIncasive ductal carcinoma of pancreas with macroscopic complete resectionJPRN-UMIN000002000Chiba study group of adjuvant chemotherapy for pancreatic cancer96
已完成
2 期
A randomized clinical trial of adjuvant chemotherapy with TS-1 versus UFT following curative operation for Stage III colorectal cancerstage III colorectal cancerJPRN-C000000346Boso Clinical Oncology Group200
招募中
2 期
Randomized phase II trial of neoadjuvant Chemotherapy with Gemcitabine and S-1 vs. without neoadjuvant chemotherapy in patients with resectable pancreatic cancerResectable pancreatic cancerJPRN-UMIN000009822Chiba study group of adjuvant chemotherapy for pancreatic cancer74
进行中（未招募）
不适用
Randomized phase II study of adjuvant chemotherapy with cisplatin + vinorelbine vs gemcitabine + vinorelbine in stage IB-IIIA radically resected non-small cell lung cancer (NSCLC) patients - MADSnon-small cell lung cancer (NSCLC)MedDRA version: 9.1Level: LLTClassification code 10061873Term: Non-small cell lung cancerEUCTR2008-000570-21-ITIST - ISTITUTO NAZIONALE PER LA RICERCA SUL CANCRO